Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Guillermo Arrossagaray"'
Autor:
Guillermo Arrossagaray, Irma Slavutsky, Marina Narbaitz, Isabel Giere, Roxana Cerretini, Marcela de Dios Soler, Andrea Rodríguez, Marcela Sarmiento, Christian Chena, Raúl Pérez Bianco
Publikováno v:
European Journal of Haematology. 71:433-438
Objectives: Genomic aberrations can now be identified in approximately 80% of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) patients. In the present study, four new structural changes involving chromosomes 17 and 12 in CLL/SLL pat
Autor:
Marcela A. Sarmiento, María Fernanda Palacios, Mariano P. Scolnik, Federico R. Ramírez, Carmen Stanganelli, Juana Cabrera, Christian P. Chena, Guillermo Arrossagaray, Irma R. Slavutsky, Raquel M. Bengio
Publikováno v:
Medicina (Buenos Aires), Vol 62, Iss 4, Pp 305-312 (2002)
En la leucemia linfática crónica (LLC) se reconocen factores pronósticos útiles como la duplicación linfocitaria, el estadio clínico y el patrón de infiltración medular. Otros, como el porcentaje de células CD38+ están en estudio y requiere
Autor:
Norma E, Riera, Marisa Rosso, Saltó, Katia, Canalejo, Marta E, Felippo, Guillermo, Arrossagaray, Mónica, Aixala, María M, de E de Bracco
Publikováno v:
Medicina. 69(4)
Occurrence of the rare CD16b deficiency ("null" phenotype) in neutrophils from two female patients (41 and 15 years old) is reported. The first case was referred with a diagnosis of anemia related to paroxistic nocturnal hemoglobinuria and the second
Autor:
Julio Cesar Sanchez Avalos, Christian Chena, Raimundo F. Bezares, Alicia Bistmans, Guillermo Arrossagaray, Karina Turdó, Irma Slavutsky
Publikováno v:
European journal of haematology. 81(2)
Background and objective: Monoallelic deletion of 13q14.3 (13q14x1) is the most common abnormality in chronic lymphocytic leukemia (CLL). As a sole alteration, it predicts a favorable outcome. Biallelic 13q14.3 (13q14x2) deletion or concomitant 13q14
Autor:
Julio Cesar Sanchez Avalos, Julieta Sanjurjo, Romina Gamberale, Paula Fernández-Calotti, Mirta Giordano, Jorge Geffner, Guillermo Arrossagaray
Publikováno v:
Leukemia research. 29(11)
Two main isoforms of Fcγ receptor II (CD32) have been described in humans: activatory FcγRIIA and inhibitory FcγRIIB. We have previously reported that B cells from a subset of chronic lymphocytic leukemia (B-CLL) patients express not only FcγRIIB
Autor:
Roxana, Cerretini, Christian, Chena, Isabel, Giere, Marcela, Sarmiento, Guillermo, Arrossagaray, Andrea, Rodríguez, Raúl, Pérez Bianco, Marcela, de Dios Soler, Marina, Narbaitz, Irma, Slavutsky
Publikováno v:
European journal of haematology. 71(6)
Genomic aberrations can now be identified in approximately 80% of chronic lymphocytic leukemia, small lymphocytic lymphoma (CLL/SLL) patients. In the present study, four new structural changes involving chromosomes 17 and 12 in CLL/SLL patients are d
Autor:
María Fernanda Palacios, Mariano Scolnik, Christian Chena, Guillermo Arrossagaray, Irma Slavutsky
Publikováno v:
Cancer genetics and cytogenetics. 146(2)
We have evaluated genomic aberrations by conventional cytogenetics and fluorescence in situ hybridization (FISH) analysis in a series of 57 Argentinean B-cell chronic lymphocytic leukemia (B-CLL) patients. The studies were performed on stimulated per
Autor:
Marcela A, Sarmientó, Mariá Fernanda, Palacios, Mariano P, Scolnik, Federico R, Ramírez, Carmen, Stanganelli, Juana, Cabrera, Christian P, Chena, Guillermo, Arrossagaray, Irma R, Slavutsky, Raquel M, Bengió
Publikováno v:
Medicina. 62(4)
Some prognostic factors are useful in chronic lymphocytic leukemia (CLL): lymphocyte doubling time, clinical stage and bone marrow pattern infiltration, while others, such as the percentage of CD38+ cells, are under study and require confirmation. Th
Autor:
Carolina, Belli, Susana, Acevedo, Raquel, Bengio, Guillermo, Arrossagaray, Nora, Watman, Norma, Rossi, Juan, García, Gabriela, Flores, Sofía, Goldztein, Irene, Larripa
Publikováno v:
Haematologica. 87(1)
Myelodysplastic syndromes (MDS) comprise a group of heterogeneous hematologic disorders with risk of leukemic evolution (LE). The French-American-British (FAB) co-operative group classifies them into five morphologic entities and the International Pr
Autor:
Carmen Stanganelli, Julio Cesar Sanchez Avalos, Christian Chena, Guillermo Arrossagaray, Irma Slavutsky
Publikováno v:
Blood. 112:4156-4156
Aberrant methylation of CpG islands of the promoter regions of tumor suppressor genes (TSG) is now considered an important epigenetic mechanism for gene inactivation. Chronic lymphocytic leukemia (CLL) is the most frequent type of adult leukemia in t